Malignant phyllodes tumor with heterologous differentiation: A rare case report.

J Cancer Res Ther

Department of Pathology, M S Ramaiah Medical College, Bangalore, KarnatakaDepartment of Pathology, M S Ramaiah Medical College, Bangalore, Karnataka, India.

Published: August 2016

Sarcomas of the breast are rare neoplasms accounting for less than 1% of breast malignancy. A 40-year-old-female with left breast mass underwent wide-excision and on histopathological examination a diagnosis of malignant phyllodes tumor with heterologous differentiation of osteosarcoma and chondrosarcoma was rendered. The heterologous elements were tumor osteoid formation and tumor chondroid formation. The rarity of the lesion was considered for reporting and on follow-up the patient was free of metastasis.

Download full-text PDF

Source
http://dx.doi.org/10.4103/0973-1482.137996DOI Listing

Publication Analysis

Top Keywords

malignant phyllodes
8
phyllodes tumor
8
tumor heterologous
8
heterologous differentiation
8
tumor
4
differentiation rare
4
rare case
4
case report
4
report sarcomas
4
sarcomas breast
4

Similar Publications

Background: Somatostatin receptors (SSTRs) are expressed in most neuroendocrine neoplasms, particularly in gastroenteropancreatic neuroendocrine tumours, and have been utilised as diagnostic markers and therapeutic targets. The radioiodinated somatostatin analogue 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid- Tyr3-octreotate (DOTATATE) has been employed for SSTR targeting for either diagnostic or therapeutic purposes depending on the labelling with Gallium or Lutetium, respectively. SSTR expression is reported in a subset of breast adenocarcinoma and breast neuroendocrine carcinomas; however, minimal knowledge exists regarding their expression in fibroepithelial (biphasic) breast lesions such as fibroadenoma and phyllodes tumours.

View Article and Find Full Text PDF

Phyllodes tumor is a type of fibroepithelial neoplasm involving the breast. This tumor is rarely reported in adolescents and the elderly and has a peak incidence in middle-aged women. Histologically, phyllodes tumors are classified as benign, borderline, or malignant.

View Article and Find Full Text PDF

A Rare Case of Primary Chondrosarcoma of the Breast: A Case Report and Comprehensive Literature Review.

Discoveries (Craiova)

September 2024

Department of Oncopathology, Homi Bhabha Cancer Hospital (HBCH) and Mahamana Pandit Madan Mohan Malviya Cancer Centre (MPMMCC), Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Varanasi, India.

Breast sarcomas are a diverse group of malignant neoplasms originating from the mammary stroma. They are uncommon tumors, often occurring as a component of other tumors. Among malignant breast mesenchymal tumors, pure sarcomas lacking epithelial components are even rarer, comprising only 0.

View Article and Find Full Text PDF

Background: Phyllodes tumors (PTs) are fibroepithelial neoplasms of the breast, with current treatment guidelines recommending wide excision to achieve surgical margins of ≥1 cm to minimize the recurrence risk. However, diagnostic challenges with core biopsy specimens often result in suboptimal surgical margins. This study aims to elucidate the correlation between margin status and PT recurrence, thereby informing surgical decision-making and enhancing patient outcomes.

View Article and Find Full Text PDF
Article Synopsis
  • Primary breast cancer in children and adolescents is rare and has distinct characteristics compared to adult cases, necessitating a study to predict survival rates in this population.
  • The study analyzed 115 pediatric patients, primarily focusing on demographic data and tumor characteristics, finding significant predictors of overall survival (OS) to be the SEER and M stages of cancer.
  • A nomogram was developed to aid in predicting OS, addressing a gap in research by providing comprehensive insights into pediatric breast cancer prognosis.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!